Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
Nicholas A. Marston, Erin A. Bohula, Ajay Bhatia, Gaetano M. De Ferrari et autres
19 citationsJAMA
Buki Ajala
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
8Publications signalées
4654Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Diabetes Treatment and ManagementBariatric Surgery and OutcomesBlood Pressure and Hypertension StudiesDiabetes Management and ResearchCoronary Interventions and Diagnostics
Publications récentes
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis
Peter Rossing, George L. Bakris, Vlado Perkovic, Richard E. Pratley et autres
17 citationsDiabetes Care
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
Akshay S. Desai, Adam Karns, Jolita Badarienė, Ahmad Aswad et autres
35 citationsJAMA
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Stefano Del Prato, Steven E. Kahn, Imre Pávó, Govinda J. Weerakkody et autres
664 citationsThe Lancet
The Canadian LMC Diabetes Registry: A Profile of the Demographics, Management, and Outcomes of Individuals with Type 1 Diabetes
Ronnie Aronson, Ruth E. Brown, Alexander Abitbol, Ronald Goldenberg et autres
28 citationsDiabetes Technology & Therapeutics
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, Rafael Díaz et autres
644 citationsThe Lancet
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, Rafael Díaz et autres
3152 citationsThe Lancet
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi, Darren K. McGuire et autres
95 citationsThe Lancet
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.